The Pressure Infusion Bags Market was valued at USD 284.43 million in 2021 and it is expected to reach USD 410.28 million in 2027, registering the CAGR of 5.89% during the forecast period (2022-2027).
The COVID-19 pandemic brought pressure infusion bags into the forefront, since the demand for them surged considerably during the COVID-19 lockdown, as the number of Covid-19 cases increased at a faster rate with growing hospital admissions. The covid-19 epidemic will have a moderate impact on the global pressure infusion bag industry. For Instance, according to the University of Pittsburgh Medical Center in February 2021, the Food and Drug Administration approved the emergency use authorization of regeneron's monoclonal antibody infusion to treat the covid 19 patients thereafter the demand for monoclonal antibodies infusion increases during covid-19. Thus, the pressure infusion market is significantly impacted by Covid-19.
Certain factors that are driving the market growth include rising prevalence of chronic diseases and surge in emergency transfusion cases and technological advancements and increasing R&D initiatives. According to World Health Organization’s update, an estimated 17.9 million people died from cardiovascular diseases in 2019, representing 32% of all global deaths. Additionally, as per the World Health Organization, the number of people aged 60 years and above will be around 1.4 billion by 2030, and by 2050, the number will be 2.1 billion. Cardiac drug infusions can be continuous or longer intermittent infusions. Therefore, as the number cardiac patient increses the the demand of infusion bags is incresing over the projecting period.
The pressure infuser has also become a necessary component of various medical procedures such as rapid infusion of blood, blood products, blood expanders, IV solutions, and invasive pressure monitoring procedures for instance, Intra‐arterial pressure monitoring and Swan‐Ganz catheterization monitoring both require the use of a pressurized plumbing system to retard the retrograde flow of blood and to keep the indwelling catheter patent. The infusor is used to pressurize a bag of heparinized saline to a pressure greater than the patient’s highest systolic blood pressure.
Additionally, manufacturers should focus more on the development of automated pressure infusers, since this will assist to address issues with manual infusion, such as poor delivery of lower quantities of infusate, the possibility of accidental air embolism, and so on. As a result of these changes, the global market for pressure infusion bags is predicted to increase significantly in the future years.
Thus all aforemention factor such as incresing number of chronic diseses as well as technological adavncement in the pressure infusion bags boost the market over the forecast period.
Key Market Trends
Outpatient Facilities show Lucrative Opportunity in the Global Pressure Infusion Bags Market
Outpatient Facility means a facility, located in or apart from a hospital, that provides, under the direction of a licensed physician, either diagnosis or treatment, or both, to ambulatory patients in need of medical, surgical, or mental care.
Throughout the past few decades, the treatment of various chronic diseases has been increasingly prioritized by the global health community or governments even in low- and middle-income countries. As a result, the demand for rapid fluid transfusion has risen significantly, in order to address the global disease burden, thus leading to a rise in utilization and adoption of Pressure Infusion Bags.
Over the past few years, with the move to value-based care, hospitals and healthcare systems are facing extreme competition from outpatient service sites, particularly those which offer physician office-based procedures, and ambulatory surgery. Gaining in popularity across the globe, outpatient facilities provide both operational and economic efficiencies, enabling ease of patient access, very competitive pricing, and increased opportunities for physician engagement. Hence, owing to all the aforementioned factors, the studied market is expected to increase in the future.
North America Dominates the Global Pressure Infusion Bags Market
North American dominates the Pressure Infusion Bags products market primarily due to high awareness regarding such health conditions. In addition, the rising prevalence of various chronic conditions is also fueling the market growth across the region.
According to World Health Organization 2021, every year, 4.4 million people die as a result of injuries, 3.16 million people die as a result of unintentional injuries, and 1.25 million people die as a result of violence-related injuries. Roughly one-third of these deaths are caused by traffic accidents, one-sixth by suicide, one-tenth by homicide, and one-sixth by war and conflict. Injuries induced consumption and dilution of clotting factors, acidosis and hypothermia in a severely injured patient commonly causes trauma-induced coagulopathy. Early infusion of blood products and early control of bleeding decreases this trauma-induced coagulopathy. hypothermia and dilutional coagulopathy are associated with infusion of large volumes of crystalloids. Hence, the predominant focus is on damage control resuscitation, which is a combination of permissive hypotension, hemorrhage control and hemostatic resuscitation. Massive transfusion protocols improve survival in severely injured patients. Early recognition that the patient will need massive blood transfusion can limit the use of crystalloids. Hence, due to the rising need for blood transfusion, the usage and adoption of pressure infusion bags is expected to grow significantly across the region.
The global Pressure Infusion Bags market is competitive and consists of a few major players. Companies like Armstrong Medical Inc., Ecomed, Merit Medical Systems, Salter Labs, Sarstedt AG & Co. KG, Smiths Medical, SunMed, Tapmedic LLC, Vyaire Medical, Inc., among others, hold the substantial market share in the market.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Diseases and Surge in Emergency Transfusion Cases
4.2.2 Technological Advancements and Increasing R&D Initiatives
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.2 By Material
5.3 By Application
5.3.1 Blood and Drug Infusion
5.3.2 Invasive Pressure Monitoring Procedures
5.4 By End-Users
5.4.1 Hospitals and Clinics
5.4.2 Outpatient Facilities
5.5.1 North America
18.104.22.168 United States
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
5.5.4 Rest of the World
6.1.1 Eakin Healthcare Group (Armstrong Medical Inc.)
6.1.2 Steris Corporation (Ecomed)
6.1.3 Merit Medical Systems
6.1.4 Salter Labs
6.1.5 Sarstedt AG & Co. KG
6.1.6 ICU Medical Inc. (Smiths Medical)
6.1.8 Tapmedic LLC
6.1.9 Vyaire Medical, Inc.
6.1.10 Spengler SAS
6.1.11 Statcorp Medical
6.1.12 Biegler GmbH
A selection of companies mentioned in this report includes:
- Eakin Healthcare Group (Armstrong Medical Inc.)
- Steris Corporation (Ecomed)
- Merit Medical Systems
- Salter Labs
- Sarstedt AG & Co. KG
- ICU Medical Inc. (Smiths Medical)
- Tapmedic LLC
- Vyaire Medical, Inc.
- Spengler SAS
- Statcorp Medical
- Biegler GmbH